BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 2842890)

  • 1. Allylamine-induced vascular toxicity in vitro: prevention by semicarbazide-sensitive amine oxidase inhibitors.
    Ramos K; Grossman SL; Cox LR
    Toxicol Appl Pharmacol; 1988 Aug; 95(1):61-71. PubMed ID: 2842890
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effect of activity of semicarbazide-sensitive aminooxidases and cellular glutathione on the cytotoxic effect of allylamine, acrolein, and formaldehyde in human cultured endothelial cells].
    Pino R; Lyles GA
    Vopr Med Khim; 1997; 43(6):537-47. PubMed ID: 9503571
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Allylamine cardiotoxicity--IV. Metabolism to acrolein by cardiovascular tissues.
    Nelson TJ; Boor PJ
    Biochem Pharmacol; 1982 Feb; 31(4):509-14. PubMed ID: 7066019
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative toxicity of allylamine and acrolein in cultured myocytes and fibroblasts from neonatal rat heart.
    Toraason M; Luken ME; Breitenstein M; Krueger JA; Biagini RE
    Toxicology; 1989 May; 56(1):107-17. PubMed ID: 2728003
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of benzylamine oxidase in the cytotoxicity of allylamine toward aortic smooth muscle cells.
    Hysmith RM; Boor PJ
    Toxicology; 1988 Oct; 51(2-3):133-45. PubMed ID: 3140421
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative cytotoxic responses of cultured avian and rodent aortic smooth muscle cells to allylamine.
    Ramos KS; Thurlow CH
    J Toxicol Environ Health; 1993 Sep; 40(1):61-76. PubMed ID: 8360943
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of plasma semicarbazide-sensitive amine oxidase in allylamine and beta-aminopropionitrile cardiovascular toxicity: mechanisms of myocardial protection and aortic medial injury in rats.
    Conklin DJ; Trent MB; Boor PJ
    Toxicology; 1999 Nov; 138(3):137-54. PubMed ID: 10593505
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Contribution of serum and cellular semicarbazide-sensitive amine oxidase to amine metabolism and cardiovascular toxicity.
    Conklin DJ; Langford SD; Boor PJ
    Toxicol Sci; 1998 Dec; 46(2):386-92. PubMed ID: 10048142
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Semicarbazide-sensitive amine oxidase activity in rat aortic cultured smooth muscle cells.
    Blicharski JR; Lyles GA
    J Neural Transm Suppl; 1990; 32():337-9. PubMed ID: 2128506
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Amine metabolism: a novel path to coronary artery vasospasm.
    Conklin DJ; Boyce CL; Trent MB; Boor PJ
    Toxicol Appl Pharmacol; 2001 Sep; 175(2):149-59. PubMed ID: 11543647
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acrolein generation stimulates hypercontraction in isolated human blood vessels.
    Conklin DJ; Bhatnagar A; Cowley HR; Johnson GH; Wiechmann RJ; Sayre LM; Trent MB; Boor PJ
    Toxicol Appl Pharmacol; 2006 Dec; 217(3):277-88. PubMed ID: 17095030
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of monoamine oxidase and semicarbazide-sensitive amine oxidase by mexiletine and related compounds.
    Eriksson M; Fowler CJ
    Naunyn Schmiedebergs Arch Pharmacol; 1984 Oct; 327(4):273-8. PubMed ID: 6514011
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduction of fat deposition by combined inhibition of monoamine oxidases and semicarbazide-sensitive amine oxidases in obese Zucker rats.
    Carpéné C; Iffiú-Soltesz Z; Bour S; Prévot D; Valet P
    Pharmacol Res; 2007 Dec; 56(6):522-30. PubMed ID: 17977742
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The deamination of n-pentylamine by monoamine oxidase and a semicarbazide-sensitive amine oxidase of rat heart.
    Guffroy C; Fowler CJ; Strolin Benedetti M
    J Pharm Pharmacol; 1983 Jul; 35(7):416-20. PubMed ID: 6136581
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An allylamine derivative (MDL 72145) with potent irreversible inhibitory actions on rat aorta semicarbazide-sensitive amine oxidase.
    Lyles GA; Fitzpatrick CM
    J Pharm Pharmacol; 1985 May; 37(5):329-35. PubMed ID: 2862241
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Properties of a semicarbazide-sensitive amine oxidase in human umbilical artery.
    Precious E; Lyles GA
    J Pharm Pharmacol; 1988 Sep; 40(9):627-33. PubMed ID: 2907029
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of glutathione S-transferase 8-8 in allylamine resistance of vascular smooth muscle cells in vitro.
    He N; Singhal SS; Awasthi S; Zhao T; Boor PJ
    Toxicol Appl Pharmacol; 1999 Jul; 158(2):177-85. PubMed ID: 10406932
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glucose handling in streptozotocin-induced diabetic rats is improved by tyramine but not by the amine oxidase inhibitor semicarbazide.
    Visentin V; Bour S; Boucher J; Prévot D; Valet P; Ordener C; Parini A; Carpéné C
    Eur J Pharmacol; 2005 Oct; 522(1-3):139-46. PubMed ID: 16202994
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Semicarbazide protection from in vivo oxidant injury of vascular tissue by allylamine.
    Awasthi S; Boor PJ
    Toxicol Lett; 1993 Feb; 66(2):157-63. PubMed ID: 8430435
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Deamination of methylamine by semicarbazide-sensitive amine oxidase in human umbilical artery and rat aorta.
    Precious E; Gunn CE; Lyles GA
    Biochem Pharmacol; 1988 Feb; 37(4):707-13. PubMed ID: 3342102
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.